Preliminary evidence of efficacy and tolerance for weekly intravenous bortezomib plus mitoxantrone in patients with advanced androgen-independent prostate cancer (AIPCa)
| dc.creator | Siefker-Radtke, A. O. | en |
| dc.creator | Poulter, V. | en |
| dc.creator | Mathew, P. | en |
| dc.creator | Tu, S. M. | en |
| dc.creator | Logothetis, C. J. | en |
| dc.creator | Papandreou, C. N. | en |
| dc.date.accessioned | 2015-11-23T10:47:18Z | |
| dc.date.available | 2015-11-23T10:47:18Z | |
| dc.date.issued | 2005 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.uri | http://hdl.handle.net/11615/33011 | |
| dc.source | Journal of Clinical Oncology | en |
| dc.source.uri | <Go to ISI>://WOS:000230326602395 | |
| dc.subject | Oncology | en |
| dc.title | Preliminary evidence of efficacy and tolerance for weekly intravenous bortezomib plus mitoxantrone in patients with advanced androgen-independent prostate cancer (AIPCa) | en |
| dc.type | journalArticle | en |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||